BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 31443665)

  • 1. LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway.
    Shi D; Wu F; Mu S; Hu B; Zhong B; Gao F; Qing X; Liu J; Zhang Z; Shao Z
    J Exp Clin Cancer Res; 2019 Aug; 38(1):375. PubMed ID: 31443665
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Luo Y; Tao H; Jin L; Xiang W; Guo W
    Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
    [No Abstract]   [Full Text] [Related]  

  • 3. Upregulation of the long non-coding RNA AFAP1-AS1 affects the proliferation, invasion and survival of tongue squamous cell carcinoma via the Wnt/β-catenin signaling pathway.
    Wang ZY; Hu M; Dai MH; Xiong J; Zhang S; Wu HJ; Zhang SS; Gong ZJ
    Mol Cancer; 2018 Jan; 17(1):3. PubMed ID: 29310682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actin filament-associated protein 1-antisense RNA1 promotes the development and invasion of tongue squamous cell carcinoma via the AFAP1-AS1/miR-133a-5p/ZIC2 axis.
    Tang M; Wu H; Zhang H; Xu X; Jiang B; Chen Q; Wei Y; Qian H; Han L
    J Gene Med; 2024 Jan; 26(1):e3654. PubMed ID: 38282153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA AFAP1-AS1 promotes osteosarcoma progression by regulating miR-497/IGF1R axis.
    Fei D; Zhang X; Lu Y; Tan L; Xu M; Zhang Y
    Am J Transl Res; 2020; 12(5):2155-2168. PubMed ID: 32509208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma.
    Deng Y; Zhao F; Zhang Z; Sun F; Wang M
    Cancer Biother Radiopharm; 2018 Nov; 33(9):365-372. PubMed ID: 29989838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer.
    Ma F; Wang SH; Cai Q; Zhang MD; Yang Y; Ding J
    Biomed Pharmacother; 2016 Dec; 84():1249-1255. PubMed ID: 27810781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
    Ye F; Tian L; Zhou Q; Feng D
    Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition.
    Li Z; Tang Y; Xing W; Dong W; Wang Z
    Exp Mol Pathol; 2018 Feb; 104(1):19-25. PubMed ID: 29246789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA AFAP1-AS1 promoting epithelial-mesenchymal transition of endometriosis is correlated with transcription factor ZEB1.
    Lin D; Huang Q; Wu R; Dai S; Huang Z; Ren L; Huang S; Chen Q
    Am J Reprod Immunol; 2019 Jan; 81(1):e13074. PubMed ID: 30506548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA AFAP1-AS1 acts as a competing endogenous RNA of miR-423-5p to facilitate nasopharyngeal carcinoma metastasis through regulating the Rho/Rac pathway.
    Lian Y; Xiong F; Yang L; Bo H; Gong Z; Wang Y; Wei F; Tang Y; Li X; Liao Q; Wang H; Zhou M; Xiang B; Wu X; Li Y; Li X; Chen X; Li G; Guo C; Zeng Z; Xiong W
    J Exp Clin Cancer Res; 2018 Oct; 37(1):253. PubMed ID: 30326930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of lncRNA AFAP1-AS1 by oridonin inhibits the epithelial-to-mesenchymal transition and proliferation of pancreatic cancer cells.
    Lou S; Xu J; Wang B; Li S; Ren J; Hu Z; Xu B; Luo F
    Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):814-825. PubMed ID: 31314060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the lncRNA ABHD11-AS
    Wu DD; Chen X; Sun KX; Wang LL; Chen S; Zhao Y
    Mol Cancer; 2017 Aug; 16(1):138. PubMed ID: 28818073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA SNHG1 negatively regulates miRNA‑101‑3p to enhance the expression of ROCK1 and promote cell proliferation, migration and invasion in osteosarcoma.
    Deng R; Zhang J; Chen J
    Int J Mol Med; 2019 Mar; 43(3):1157-1166. PubMed ID: 30592267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhoC/ROCK2 promotes vasculogenic mimicry formation primarily through ERK/MMPs in hepatocellular carcinoma.
    Zhang JG; Zhang DD; Liu Y; Hu JN; Zhang X; Li L; Mu W; Zhu GH; Li Q; Liu GL
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1113-1125. PubMed ID: 30779947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction to: LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway.
    Shi D; Wu F; Mu S; Hu B; Zhong B; Gao F; Qing X; Liu J; Zhang Z; Shao Z
    J Exp Clin Cancer Res; 2020 Apr; 39(1):72. PubMed ID: 32340613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA AFAP1-AS1 facilitates tumor growth and promotes metastasis in colorectal cancer.
    Han X; Wang L; Ning Y; Li S; Wang Z
    Biol Res; 2016 Aug; 49(1):36. PubMed ID: 27578191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression.
    Dai JH; Huang WZ; Li C; Deng J; Lin SJ; Luo J
    Cell Cycle; 2019 Oct; 18(20):2727-2741. PubMed ID: 31432728
    [No Abstract]   [Full Text] [Related]  

  • 19. Long non-coding RNA SNHG5 sponges miR-26a to promote the tumorigenesis of osteosarcoma by targeting ROCK1.
    Wang Z; Wang Z; Liu J; Yang H
    Biomed Pharmacother; 2018 Nov; 107():598-605. PubMed ID: 30114643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
    Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C
    Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.